Study authors conducted a retrospective analysis over a 5-year period to analyze health care resource utilization among CRSwNP patients and identify areas for quality improvement.
Researchers evaluated the immunogenicity and reactogenicity of COVID-19 mRNA vaccines in pregnant and lactating women compared with women who were not pregnant and those who were naturally infected with SARS-CoV-2 during pregnancy.
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Researchers assessed whether patients with osteoarthritis and NSAID allergies have higher odds of developing opioid use disorder, and identified next steps to be considered for this patient population.
